Manufacturing pharmaceutical agent in administrable or implantable form having controlled liberation of principle active compound, comprises mixing the compound to vector and subjecting the mixture to isostatic high pressure treatment

摘要

Manufacturing a pharmaceutical agent (A) in an administrable or implantable form having controlled liberation of principle active compound (I) comprises: mixing (I) to a vector comprising one or more excipients; and subjecting the mixture to a treatment by isostatic high pressure (100-700 MPa) for 60 minutes. An independent claim is also included for (I).